Aurovela Fe 1/20 Kit
Product Images NDC 65862-940

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Aurovela Fe 1/20 (NDC 65862-940). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Norethindroneethinyl Fig1)

A bar chart titled 'Circulatory Disease Mortality Rates per 100,000 Woman Years by Age, Smoking Status and Oral Contraceptive Use.' The chart compares mortality rates among four groups: ever-users (non-smokers), ever-users (smokers), controls (non-smokers), and controls (smokers) across four age groups: 15-24, 25-34, 35-44, and 45+. Mortality rates increase with age, especially for ever-users who smoke.*

FDA Label Image

Figure 2 (Norethindroneethinyl Fig2)

A forest plot showing effect estimates and confidence intervals for studies comparing Ever Combined Oral Contraceptive (COC) use versus Never COC use, and Current COC use versus Never Use. The graph presents odds ratios (OR), hazard ratios (HR), and risk ratios (RR) from various women's health studies overlaid with a vertical line at an effect estimate of 1.00 for reference.*

FDA Label Image

Figure3 (Norethindroneethinyl Fig3)

An illustrated medication guide for Aurovela Fe 1/20 kit showing a 28-day pill schedule with four rows labeled Week 1 to Week 4, each containing pills arranged by days of the week (Sunday to Saturday). The first three weeks contain light yellow to yellow pills, and the fourth week contains brown pills. Instructions indicate to start on the pill labeled for the first day of the period and take pills left to right each week.*

FDA Label Image

Package Label-principal Display Panel (1 mg/20 mcg and 75 mg Pouch Label)

An instructional diagram for Aurovela Fe 1/20 oral contraceptive kit showing a weekly pill calendar with columns labeled SUN to SAT and rows labeled WEEK 1 to WEEK 4. It includes guidance on pill-taking order from left to right each week and instructions for Sunday starters versus Day-1 starters.*

FDA Label Image

Package Label-principal Display Panel (1 mg/20 mcg and 75 mg Blister Carton)

Packaging label for Aurovela Fe 1/20, a kit containing tablets with norethindrone acetate, ethinyl estradiol, and ferrous fumarate. The label states a 28-day regimen with 21 light yellow tablets and 7 brown tablets per pouch. It includes dosage, storage instructions, and manufacturer Aurobindo Pharma Limited, with NDC 65862-940-87. The label also has space for pharmacy labeling and barcode.*

FDA Label Image

Norethindroneethinyl Fig6

Packaging label for Aurovela Fe 1/20, a kit containing Norethindrone Acetate and Ethinyl Estradiol Tablets USP and Ferrous Fumarate Tablets. The label states the product includes 5 pouches, each with 28 tablets, distributed by Aurobindo Pharma USA Inc. It features a 28-day regimen and dosage instructions, emphasizing it is for prescription use only. The label includes warnings about pregnancy prevention and notes the tablets' specific active ingredient amounts.*

FDA Label Image

Chemical Structure (Norethindroneethinyl Str1)

Chemical structure of Norethindrone Acetate, showing its molecular arrangement with labeled acetyl and alkyne groups as part of the steroid framework.*

FDA Label Image

Chemical Structure (Norethindroneethinyl Str2)

Chemical structure diagram of Ethinyl Estradiol, showing its molecular formula with labeled components and chemical bonds as part of the active ingredients in Aurovela Fe 1/20.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.